Clinical research - Press Releases

Date	Title	Company
21-Dec-2022	Orgenesis and Kurve Therapeutics announce pre-clinical study results for a cell-based oncolytic virus bearing product demonstrating over 50 percent reduction in a murine glioblastoma model	Orgenesis and Kurve Therapeutics
21-Dec-2022	AlzeCure gets abstract accepted on new potential disease-modifying effects of ACD856 against Alzheimer's	AlzeCure
21-Dec-2022	Mainz Biomed Enrolls First Patient in eAArly DETECT Study Evaluating Integration of Novel mRNA Biomarkers into ColoAlert	Mainz Biomed
16-Dec-2022	SAMDI Tech’s Dr. Zachary Gurard-Levin Elected to Society of Laboratory Automation and Screening (SLAS) Board	SAMDI Tech, Inc.
15-Dec-2022	Almac Group secures HPRA certification for biologics testing	Almac
15-Dec-2022	AI Diagnosis of Hip Misalignments Proves Reliable, Fast and Cost Efficient	ImageBiopsy Lab
14-Dec-2022	Targeted Timing of Palliative Care for Lung Cancer	KL Krems
14-Dec-2022	Conference Co-chairs from Merck & AstraZeneca invitation to join 3D Cell Culture	SAE Media Group
13-Dec-2022	Curebase Releases Diagnostic Offering that Delivers First All-Inclusive Package of Software and Services Needed to Fully Execute Diagnostic Studies	Curebase
13-Dec-2022	CluePoints Appoints Andy Cooper as New Chief Executive Officer	CluePoints
13-Dec-2022	1ST Biotherapeutics, Inc., Announces FDA Clearance of IND Application for Phase 1/2 Study of FB849 to Treat Patients with Advanced Solid Tumors	1ST Biotherapeutics, Inc.
08-Dec-2022	PHASTAR Joins Oncology Development Programme (ODP2) to Accelerate Development of Novel Cancer Innovations	PHASTAR
08-Dec-2022	MetrioPharm Announces Topline Data of its Phase IIa Study of MP1032 in COVID-19 Patients	MetrioPharm AG
07-Dec-2022	PHASTAR Launches Pro-Bono Scheme for Charities	Phastar
07-Dec-2022	The Lancet Publishes Results from Two Bimekizumab Phase 3 Studies in Psoriatic Arthritis	UCB
07-Dec-2022	Enterome presents two posters on Phase 2 data of its lead immunotherapy, EO2401, in recurrent glioblastoma (ROSALIE study) at ESMO IO 2022	Enterome
06-Dec-2022	MHRA approves Adtralza®▼(tralokinumab) for the treatment of adolescent patients with moderate-to-severe atopic dermatitis, who are candidates for systemic therapy	LEO Pharma
06-Dec-2022	Pumas-AI Hires Dr. Salim Bouchene and Expands Consulting Practice in Europe	Pumas-AI
06-Dec-2022	Platelet Services celebrates record year	Platelet Services
06-Dec-2022	Mainz Biomed Announces IRB Approval and Initiation of US Pivotal FDA Clinical Study	Mainz Biomed